Brief: Paion Announces Submission Of New Drug Application For Remimazolam In Japan
Dec 21 (Reuters) - Paion AG PA8G.DE :
* ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION FOR
REMIMAZOLAM BY
ITS PARTNER MUNDIPHARMA IN JAPAN
* SUBMISSION TRIGGERS MILESTONE PAYMENTS TO PAION TOTALING
EUR 2
MILLION
Source text for Eikon: ID:nEQ56nXMYa
Further company coverage: PA8G.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on PAION AG
See all newsBrief: Paion AG To Issue Approx 4.8 Mln Shares In Capital Increase With Subscription Rights
Brief: Paion AG Reports Developments On Commercial Activities In Europe
Brief: Paion Q1 EBITDA Up At EUR 15 Mln
Brief: Paion Grants Exclusive License To Cristália For Development And Commercialization Of Remimazolam In Latin America
Brief: Paion Announces Sebastian Werner As New CFO, Effective 1 June 2022